Browse studies

Find your next paid study

27,384 recruiting studies available now

A PHASE 1/2A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, SINGLE AND MULTIPLE ASCENDING DOSE STUDY TO INVESTIGATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF MET233 CO-ADMINISTERED WITH MET097 IN ADULT PARTICIPANTS WITH OBESITY OR OVERWEIGHT INCLUDING PARTICIPANTS WITH TYPE 2 DIABETES MELLITUS

This study is designed to test how well the combination of MET233 with MET097 works to treat individuals with obesity or overweight with or without diabetes.

Obesity and Obesity-related Medical Conditions

Estimated

~$500 – $11,250

Actual pay is set by the research site.

PfizerNCT06924320

Observational

Feasibility of a Multi-Channel Intervention to Promote Colorectal Cancer Screening Among American Indians in Oklahoma

The Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS) Program addresses major regional CRC screening disparities a…

CRC ScreeningCRC (Colorectal Cancer)

Estimated

~$10 – $750

Actual pay is set by the research site.

University of OklahomaNCT07254910

Prevalence of Brain Health Versus Neurodegeneration in Former Professional Football Players

This project will define the prevalence of brain health (i.e., normal cognitive, neuromotor, behavioral function) in living professional football retirees and …

Traumatic Brain Injury

Estimated

~$10 – $1,125

Actual pay is set by the research site.

David Okonkwo, MD, PhDNCT04708613

Phase 2

Exogenous Ketone Ester Supplementation in ICU Delirium (KETONES ICU)

Delirium is a common syndrome in intensive care unit (ICU) patients. Those experiencing delirium may suddenly feel confused, have trouble thinking clearly, str…

ICU DeliriumCritical Illness

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Vanderbilt University Medical CenterNCT07364162

Cardiometabolic Disease, Substrate Metabolism, and Abnormal Placental Pathology: a Multimodal Maternal-Fetal Study

This study's primary purpose is to determine the potential relationship between cardiometabolic disease, specifically insulin resistance (HOMA-IR), and materna…

PreeclampsiaGestational Diabetes Mellitus (GDM)Preeclampsia (PE)+9 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of Tennessee Graduate School of MedicineNCT07565727

Observational

Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)

This is a phase 2 pragmatic study that evaluates the clinical benefit of continuing systemic therapy with the addition of locally ablative therapies for oligo-…

Breast CancerOligoprogressiveHead and Neck Cancer+2 more

Estimated

~$10 – $750

Actual pay is set by the research site.

University of California, DavisNCT06103669

Cognitive Aging in Older Long-term Breast Cancer Survivors

The purpose of this study is to look at how differences in cognitive (mental) function develop over time in breast cancer survivors compared to volunteers with…

Breast Cancer Survivors

Estimated

~$10 – $750

Actual pay is set by the research site.

Memorial Sloan Kettering Cancer CenterNCT06334354

Phase 1

A Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer

Molecular Imaging (MI) uses tracers which emit radiation to provide clinically valuable imaging for patient with cancer. Most current MI agents utilize Fluorin…

Prostate Adenocarcinoma

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Hoag Memorial Hospital PresbyterianNCT06736054

Phase 2

A Single Arm Open-label, Phase II Study of Sipuleucel-T With Bipolar Androgen Therapy in Men With Metastatic Castration-resistant Prostate Cancer

This is an open-label, single-arm phase II study of bipolar androgen therapy (BAT) given in addition with standard of care Sipuleucel-T to determine the interf…

Metastatic Castration-resistant Prostate Cancer

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Yale UniversityNCT06100705

Phase 1

TulmiSTAR-01: A Two-part, Phase I Dose Escalation and Expansion Followed by a Randomized, Open-label Multicenter, Phase II Study to Assess the Safety and Efficacy of the Combination of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) vs Standard of Care in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer

This is a two-part, Phase I/II, open-label, global, multicenter study assessing the safety and efficacy of the combination of tulmimetostat (DZR123) and JSB462…

Progressive Metastatic Castrate Resistant Prostate Cancer

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Novartis PharmaceuticalsNCT07206056

Observational

Outpatient Recovery From Acute Kidney Injury Requiring Dialysis - 2

Providing additional information to patients with acute kidney injury who continue dialysis after hospital discharge and to the accepting kidney doctor (nephro…

AKIAKI - Acute Kidney InjuryDialysis Patients

Estimated

~$10 – $675

Actual pay is set by the research site.

University of California, San FranciscoNCT07106151

Understanding Stroke Outcomes: Stroke Resilience, Infarct Burden, and Long-Term Cognition

Background: Stroke is the fifth leading cause of death in the United States. It is also a leading cause of disability. More than 70% of people who survive str…

StrokeBrain DiseaseVascular Diseases+1 more

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Neurological Disorders and Stroke (NINDS)NCT06615973